Abstract
Purpose to evaluate and correlate the alterations of microvascular and chorioretinal structure in Type 2 diabetes mellitus (T2DM) patients without clinical signs of DR.
Methods T2DM patients were randomized sampled from Guangzhou Diabetic Eye Study and healthy controls from the community of Guangzhou, China were recruited in this cross-sectional study. Demographic, clinical and ocular parameters were regularly obtained. Retinal thickness (RT), retinal nerve fiber layer (RNFL) thickness, ganglion cell-inner plexiform layer (GC-IPL) thickness, outer retina layer (ORL) thickness and choroid thickness (CT) were automatically evaluated by swept-source optical coherence tomography (SS-OCT) in the 1, 3, and 6 mm centered on fovea. Vessel density (VD) was obtained by OCT angiography (OCTA) in the 1 and 3 mm centered on the fovea.
Results 1,444 eyes of 1,444 individuals (722 T2DM patients and 722 healthy controls) were included in the final analyses. Macular average RNFL was thinned (P < 0.001), average GC-IPL was thickened (P < 0.001), and ORL was thickened (P = 0.012) in DM patients compared with healthy controls independent of confounding factors. VD was significantly increased in diabetic patients without DR. Correlations were found between VD and specific layers of retina both in DM patients and in healthy controls. Especially in DM patients, average RT in positively related with parafoveal VD (β= 0.010, 95%CI: 0.003 to 0.017) and total average VD (β= 0.010,95%CI: 0.003 to 0.016). Specifically, RNFL thickness is inversely related with VD, while both GC-IPL and ORL thickness are positively related with VD in diabetic patients without DR.
Conclusion This study reports and correlates the early alterations of chorioretinal structure and retinal superficial vessels in T2DM patients even before the onset of clinical signs of DR. Findings of this study may provide novel insights to explore the pathogenesis of DR.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Guangdong Province Science & Technology Plan (Grant no. 2014B020228002).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institute Ethics Committee of ZOC (2017KYPJ094)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The availability of all data referred to in the manuscript and note links below.
